ImmunoBiome
Pohang
About ImmunoBiome
ImmunoBiome aims to develop microbiome therapeutics to treat incurable diseases like cancer and autoimmune diseases based on our top-notch immunology, bioinformatics, and microbiome-oriented basic research.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $27.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2021)
- Website: en.immunobiome.co.kr
- Phone: +82-10-6890-7352
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/immunobiome-140041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.